• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CEUS LI-RADS:图文综述。

CEUS LI-RADS: a pictorial review.

作者信息

Bartolotta Tommaso Vincenzo, Terranova Maria Chiara, Gagliardo Cesare, Taibbi Adele

机构信息

BiND Department: Biomedicine, Neuroscience and Advanced Diagnostic, University of Palermo, Via Del Vespro, 129 90127, Palermo, Italy.

Department of Radiology, Fondazione Istituto Giuseppe Giglio Ct.da Pietrapollastra, Via Pisciotto, 90015, Cefalù (Palermo), Italy.

出版信息

Insights Imaging. 2020 Feb 4;11(1):9. doi: 10.1186/s13244-019-0819-2.

DOI:10.1186/s13244-019-0819-2
PMID:32020352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7000618/
Abstract

Contrast-enhanced ultrasound (CEUS) greatly improved the diagnostic accuracy of US in the detection and characterization of focal liver lesions (FLLs), and it is suggested and often included in many international guidelines as an important diagnostic tool in the imaging work-up of cirrhotic patients at risk for developing hepatocellular carcinoma (HCC). In particular, CEUS Liver Imaging Reporting and Data System (LI-RADS) provides standardized terminology, interpretation, and reporting for the diagnosis of HCC. The aim of this pictorial essay is to illustrate CEUS features of nodules discovered at US in cirrhotic liver according to LI-RADS categorization.

摘要

超声造影(CEUS)极大地提高了超声在检测和鉴别肝脏局灶性病变(FLLs)方面的诊断准确性,并且在许多国际指南中被推荐并经常作为对有肝细胞癌(HCC)发生风险的肝硬化患者进行影像学检查的重要诊断工具。特别是,CEUS肝脏影像报告和数据系统(LI-RADS)为HCC的诊断提供了标准化的术语、解读和报告。本图谱文章的目的是根据LI-RADS分类阐述在肝硬化肝脏超声检查中发现的结节的CEUS特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/1a880269c6dc/13244_2019_819_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/d71aee15edb5/13244_2019_819_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/051afc4052f6/13244_2019_819_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/f75d53673d7b/13244_2019_819_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/848cbb6d3ab9/13244_2019_819_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/f666b6bdb43f/13244_2019_819_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/e6e2463a9f54/13244_2019_819_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/747477f46f24/13244_2019_819_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/45f7c0e4a2eb/13244_2019_819_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/dbfeda275bda/13244_2019_819_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/c17fd15e5540/13244_2019_819_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/4f5f2cbd7b60/13244_2019_819_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/8fe34bb560c1/13244_2019_819_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/1a880269c6dc/13244_2019_819_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/d71aee15edb5/13244_2019_819_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/051afc4052f6/13244_2019_819_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/f75d53673d7b/13244_2019_819_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/848cbb6d3ab9/13244_2019_819_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/f666b6bdb43f/13244_2019_819_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/e6e2463a9f54/13244_2019_819_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/747477f46f24/13244_2019_819_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/45f7c0e4a2eb/13244_2019_819_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/dbfeda275bda/13244_2019_819_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/c17fd15e5540/13244_2019_819_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/4f5f2cbd7b60/13244_2019_819_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/8fe34bb560c1/13244_2019_819_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2de/7000618/1a880269c6dc/13244_2019_819_Fig13_HTML.jpg

相似文献

1
CEUS LI-RADS: a pictorial review.CEUS LI-RADS:图文综述。
Insights Imaging. 2020 Feb 4;11(1):9. doi: 10.1186/s13244-019-0819-2.
2
Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.肝硬化患者肝结节中标准化对比增强超声(CEUS)及 CEUS 算法(CEUS LI-RADS®/ESCULAP)的真实世界评估 - 一项前瞻性多中心研究。
Eur Radiol. 2021 Oct;31(10):7614-7625. doi: 10.1007/s00330-021-07872-3. Epub 2021 Apr 15.
3
Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.CEUS LI-RADS 在肝癌风险患者中对 20mm 或更小的肝脏结节的特征诊断准确性。
Radiology. 2020 Feb;294(2):329-339. doi: 10.1148/radiol.2019191086. Epub 2019 Dec 3.
4
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.
5
The interreader agreement and validation of contrast-enhanced ultrasound liver imaging reporting and data system.超声造影肝脏影像报告与数据系统的读者间一致性和验证。
Eur J Radiol. 2019 Nov;120:108685. doi: 10.1016/j.ejrad.2019.108685. Epub 2019 Oct 7.
6
Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.超声造影对肝细胞癌鉴别诊断的诊断准确性:爱克发与CEUS-LI-RADS对比
Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1036-1044. doi: 10.1097/MEG.0000000000000916.
7
Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.高危人群肝细胞癌无创诊断标准化算法的观察者间和模态间一致性:CEUS-LI-RADS 与 MRI-LI-RADS。
Eur Radiol. 2018 Oct;28(10):4254-4264. doi: 10.1007/s00330-018-5379-1. Epub 2018 Apr 19.
8
LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.肝脏影像报告和数据系统-超声造影 - 关于高危人群肝细胞癌诊断的超声造影算法提案
Ultraschall Med. 2016 Dec;37(6):627-634. doi: 10.1055/s-0042-112221. Epub 2016 Aug 3.
9
Contrast-Enhanced Ultrasound Algorithms (CEUS-LIRADS/ESCULAP) for the Noninvasive Diagnosis of Hepatocellular Carcinoma - A Prospective Multicenter DEGUM Study.用于肝细胞癌无创诊断的对比增强超声算法(CEUS-LIRADS/ESCULAP)——一项前瞻性多中心德国超声医学与医学工程学会研究
Ultraschall Med. 2021 Apr;42(2):178-186. doi: 10.1055/a-1198-4874. Epub 2020 Jul 14.
10
Usefulness of the Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Focal Liver Lesions by Inexperienced Radiologists.超声造影肝脏成像报告和数据系统在非经验丰富的放射科医生诊断肝脏局灶性病变中的应用价值
J Ultrasound Med. 2020 Aug;39(8):1537-1546. doi: 10.1002/jum.15242. Epub 2020 Feb 20.

引用本文的文献

1
Non-Invasive Kupffer-CEUS Enhances the Accuracy of Focal Liver Lesions Diagnosis in Patients with Liver Cirrhosis or Fibrosis: A Prospective Multicenter Study from China.非侵入性库普弗细胞增强超声造影提高肝硬化或肝纤维化患者局灶性肝病变诊断准确性:一项来自中国的前瞻性多中心研究
Liver Cancer. 2025 Jan 22;14(4):435-445. doi: 10.1159/000543501. eCollection 2025 Aug.
2
Integrating CEUS Imaging Features and LI-RADS Classification for Postoperative Early Recurrence Prediction in Solitary Hepatocellular Carcinoma: A Machine Learning-Based Prognostic Approach.整合对比增强超声成像特征与LI-RADS分类用于预测孤立性肝细胞癌术后早期复发:一种基于机器学习的预后方法
J Hepatocell Carcinoma. 2025 Jul 3;12:1287-1300. doi: 10.2147/JHC.S530848. eCollection 2025.
3

本文引用的文献

1
Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?肝细胞癌的超声造影:我们目前的进展如何?
Ultrasonography. 2019 Jul;38(3):200-214. doi: 10.14366/usg.18060. Epub 2019 Feb 25.
2
Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI.局灶性结节性增生:基于体重的钆贝葡胺与钆塞酸二钠增强 MRI 的个体内比较。
Diagn Interv Radiol. 2019 Mar;25(2):95-101. doi: 10.5152/dir.2019.18165.
3
MRI assessment of hepatocellular carcinoma after locoregional therapy.
Diagnostic performance of contrast-enhanced ultrasonography for predicting therapeutic response to radiofrequency ablation in patients with hepatocellular carcinoma: a meta-analysis.超声造影预测肝细胞癌患者射频消融治疗反应的诊断性能:一项荟萃分析。
Discov Oncol. 2025 Jul 1;16(1):1237. doi: 10.1007/s12672-025-03008-x.
4
Contrast-enhanced ultrasound characteristics in orbital cavernous venous malformation.眼眶海绵状静脉畸形的超声造影特征
Exp Ther Med. 2025 May 16;30(1):137. doi: 10.3892/etm.2025.12887. eCollection 2025 Jul.
5
Using multimodal ultrasound technology to improve the success rate of liver tumor puncture for lesions with poor visibility on conventional ultrasound imaging.使用多模态超声技术提高常规超声成像下可见性差的肝脏肿瘤穿刺成功率。
Quant Imaging Med Surg. 2025 Jan 2;15(1):801-812. doi: 10.21037/qims-24-1392. Epub 2024 Dec 30.
6
Contrast vector imaging for differential diagnosis of focal liver lesions: Analysis of tumoral vascular structures and flow characteristics.对比向量成像在肝脏局灶性病变鉴别诊断中的应用:肿瘤血管结构及血流特征分析
PLoS One. 2024 Dec 3;19(12):e0314263. doi: 10.1371/journal.pone.0314263. eCollection 2024.
7
Unraveling distinctions between contrast-enhanced ultrasound and CT/MRI for liver mass diagnosis.解析超声造影与CT/MRI在肝脏肿块诊断中的差异
Ultrasonography. 2025 Jan;44(1):19-30. doi: 10.14366/usg.24163. Epub 2024 Oct 16.
8
Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques.肝细胞癌的先进成像:当前及新技术综述
J Gastrointest Cancer. 2024 Dec;55(4):1469-1484. doi: 10.1007/s12029-024-01094-8. Epub 2024 Aug 19.
9
Evaluation of combined hepatocellular-cholangiocarcinoma using CEUS LI-RADS: correlation with pathological characteristics.使用CEUS LI-RADS对肝内胆管癌-肝细胞癌混合型进行评估:与病理特征的相关性
Abdom Radiol (NY). 2025 Feb;50(2):646-655. doi: 10.1007/s00261-024-04519-x. Epub 2024 Aug 16.
10
Training on contrast-enhanced ultrasound LI-RADS classification for resident radiologists: a retrospective comparison of performance after training.住院放射科医师的超声造影LI-RADS分类培训:培训后表现的回顾性比较
Insights Imaging. 2024 Aug 14;15(1):205. doi: 10.1186/s13244-024-01786-6.
局部区域治疗后肝细胞癌的磁共振成像评估
Insights Imaging. 2019 Jan 29;10(1):8. doi: 10.1186/s13244-019-0690-1.
4
The "spoke wheel" sign in hepatic focal nodular hyperplasia.肝局灶性结节性增生中的“辐轮”征。
Abdom Radiol (NY). 2019 Mar;44(3):1183-1184. doi: 10.1007/s00261-018-1852-1.
5
Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.高危患者肝内胆管细胞癌与肝细胞癌的鉴别诊断:应用超声造影的预测模型。
World J Gastroenterol. 2018 Sep 7;24(33):3786-3798. doi: 10.3748/wjg.v24.i33.3786.
6
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南:肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
7
How to perform Contrast-Enhanced Ultrasound (CEUS).如何进行超声造影(CEUS)。
Ultrasound Int Open. 2018 Jan;4(1):E2-E15. doi: 10.1055/s-0043-123931. Epub 2018 Feb 7.
8
Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis.超声造影在肝脏局灶性病变中的应用特征:一项综合荟萃分析。
Eur Radiol. 2018 May;28(5):2077-2088. doi: 10.1007/s00330-017-5152-x. Epub 2017 Nov 30.
9
Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group.肝脏对比增强超声:ACR CEUS LI-RADS 工作组的技术和词汇推荐。
Abdom Radiol (NY). 2018 Apr;43(4):861-879. doi: 10.1007/s00261-017-1392-0.
10
2017 Version of LI-RADS for CT and MR Imaging: An Update.2017 版 CT 和 MR 成像肝脏影像学报告和数据系统:更新。
Radiographics. 2017 Nov-Dec;37(7):1994-2017. doi: 10.1148/rg.2017170098.